Stem cell shot aims to strengthen brittle bones in High-Risk women
NCT ID NCT06949137
First seen Feb 17, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This early-stage study tests the safety of a new stem cell treatment called HMM910 for postmenopausal women with severe osteoporosis who are at high risk of breaking a bone. Nine women aged 45 to 85 will receive the injection and be monitored for side effects. The goal is to see if the treatment is safe enough to study further.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HELP Therapeutics
Nanjing, Jiangsu, 210000, China
Conditions
Explore the condition pages connected to this study.